<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many kinase inhibitors, chemotherapeutic agents, <z:chebi fb="0" ids="50919">antiemetics</z:chebi>, antibiotics, and antifungal agents can prolong QT intervals, placing the patient as risk for the life-threatening <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> <z:hpo ids='HP_0001664'>Torsade de pointes</z:hpo> (Tdp) </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, common <z:e sem="disease" ids="C0852198,C0342579" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">electrolyte imbalances</z:e> experienced by many patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compound the risk </plain></SENT>
<SENT sid="2" pm="."><plain>Because numerous medications used in <z:hpo ids='HP_0002664'>oncology</z:hpo> and common <z:e sem="disease" ids="C0852198,C0342579" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">electrolyte imbalances</z:e> in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> increase the risk for Tdp, <z:hpo ids='HP_0002664'>oncology</z:hpo> nurses must be informed about this life-threatening <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>